Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal cisplatin + paclitaxel versus cisplatin + paclitaxel in inoperable non-small-cell lung cancer
ACTRN12610000046000Phase 3Completed
- Sponsor
- George P. Stathopoulos
- Start
- Sep 2007
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, open-label trial of lipoplatin, cisplatin and paclitaxel in non-small cell lung cancer (NSCLC) (2 arms), sponsored by George P. Stathopoulos. Primary endpoint: Response rate. Started Sep 2007; status: completed.
02
Drugs
lipoplatincisplatinpaclitaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ACTRN12610000046000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000046000.